Long non-coding RNAs and complex diseases: From experimental results to computational models

Briefings in Bioinformatics

Volumn 18, Issue 4, 2017, Pages 558-576

  Chen, Xing ^a   Yan, Chenggang Clarence ^b   Zhang, Xu ^c   You, Zhu Hong ^a  

^a CHINA UNIVERSITY OF MINING AND TECHNOLOGY   (China)

^b HANGZHOU DIANZI UNIVERSITY   (China)

^c SHANDONG UNIVERSITY   (China)

Author keywords

Biological network; Complex disease; Computational model; LncRNA disease association prediction; Long non coding RNA; Machine learning

Indexed keywords

LONG UNTRANSLATED RNA;

ALGORITHM; BIOLOGY; COMPUTER SIMULATION; GENETICS; HUMAN;

ALGORITHMS; COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; HUMANS; RNA, LONG NONCODING;

EID: 85027149996     PISSN: 14675463     EISSN: 14774054     Source Type: Journal    
DOI: 10.1093/bib/bbw060     Document Type: Article

References (215)

1. Yanofsky C. Establishing the triplet nature of the genetic code. Cell 2007;128:815-8
2. Taft RJ, Pang KC, Mercer TR, et al. Non-coding RNAs: regulators of disease. J Pathol 2010;220:126-39
3. Wilusz JE, Sunwoo H, Spector DL. Long noncoding RNAs: functional surprises from the RNA world. Genes Dev 2009;23:1494-504
4. Core LJ, Waterfall JJ, Lis JT. Nascent RNA sequencing reveals widespread pausing and divergent initiation at human promoters. Science 2008;322:1845-8
5. Bertone P, Stolc V, Royce TE, et al. Global identification of human transcribed sequences with genome tiling arrays. Science 2004;306:2242-6
6. Crick F, Barnett L, Brenner S, et al. General nature of the genetic code for proteins. Nature 1961;192:1227-32
7. Mohanty V, Gökmen-Polar Y, Badve S, et al. Role of lncRNAs in health and disease-size and shape matter. Brief Funct Genomics 2015;14:115-29
8. Chen X, Yan CC, Luo C, et al. Constructing lncRNA functional similarity network based on lncRNA-disease associations and disease semantic similarity. Sci Rep 2015;5:11338
9. Taft RJ, Pheasant M, Mattick JS. The relationship between non-protein-coding DNA and eukaryotic complexity. Bioessays 2007;29:288-99
10. Esteller M. Non-coding RNAs in human disease. Nat Rev Genetics 2011;12:861-74
11. Harrow J, Frankish A, Gonzalez JM, et al. GENCODE: the reference human genome annotation for The ENCODE Project. Genome Res 2012;22:1760-74
12. Derrien T, Johnson R, Bussotti G, et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res 2012;22:1775-89
13. Guttman M, Russell P, Ingolia NT, et al. Ribosome profiling provides evidence that large noncoding RNAs do not encode proteins. Cell 2013;154:240-51
14. Zhao W, Luo J, Jiao S. Comprehensive characterization of cancer subtype associated long non-coding RNAs and their clinical implications. Sci Rep 2014;4:6591
15. Lu Q, Ren S, Lu M, et al. Computational prediction of associations between long non-coding RNAs and proteins. BMC Genomics 2013;14:651
16. Li J, Xuan Z, Liu C. Long non-coding RNAs and complex human diseases. Int J Mol Sci 2013;14:18790-808
17. Bussemakers MJ, van Bokhoven A, Verhaegh GW, et al. DD3: a new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Res 1999;59:5975-9
18. Managadze D, Rogozin IB, Chernikova D, et al. Negative correlation between expression level and evolutionary rate of long intergenic noncoding RNAs. Genome Biol Evol 2011;3:1390-404
19. Schonrock N, Harvey RP, Mattick JS. Long noncoding RNAs in cardiac development and pathophysiology. Circ Res 2012;111:1349-62
20. Bhartiya D, Kapoor S, Jalali S, et al. Conceptual approaches for lncRNA drug discovery and future strategies. Expert Opin Drug Discov 2012;7:503-13
21. Gupta RA, Shah N, Wang KC, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010;464:1071-6
22. Chung S, Nakagawa H, Uemura M, et al. Association of a novel long non-coding RNA in 8q24 with prostate cancer susceptibility. Cancer Sci 2011;102:245-52
23. Cui Z, Ren S, Lu J, et al. The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor. Urol Oncol 2013;31:1117-23
24. Pibouin L, Villaudy J, Ferbus D, et al. Cloning of the mRNA of overexpression in colon carcinoma-1: a sequence overexpressed in a subset of colon carcinomas. Cancer Genet Cytogenet 2002;133:55-60
25. Zhang X, Zhou Y, Mehta KR, et al. A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells. J Clin Endocrinol Metab 2003;88:5119-26
26. Faghihi MA, Modarresi F, Khalil AM, et al. Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of b-secretase. Nat Med 2008;14:723-30
27. Congrains A, Kamide K, Oguro R, et al. Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A/B. Atherosclerosis 2012;220:449-55
28. Calin GA, Liu C-G, Ferracin M, et al. Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell 2007;12:215-29
29. Alvarez ML, Di Stefano JK. Functional characterization of the plasmacytoma variant translocation 1 gene (PVT1) in diabetic nephropathy. PLoS One 2011;6:e18671
30. Zhang Q, Chen C-Y, Yedavalli VS, et al. NEAT1 long noncoding RNA and paraspeckle bodies modulate HIV-1 posttranscriptional expression. MBio 2013;4:e00596-12
31. Johnson R. Long non-coding RNAs in Huntington's disease neurodegeneration. Neurobiol Dis 2012;46:245-54
32. Yang Z, Zhou L, Wu L-M, et al. Overexpression of long noncoding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. Ann Surg Oncol 2011;18:1243-50
33. van Poppel H, Haese A, Graefen M, et al. The relationship between Prostate CAncer gene 3 (PCA3) and prostate cancer significance. BJU Int 2012;109:360-6
34. Zhang Z, Hao H, Zhang C, et al. Evaluation of novel gene UCA1 as a tumor biomarker for the detection of bladder cancer. Zhonghua Yi Xue Za Zhi 2012;92:384-7
35. Chen X, Yan G-Y. Novel human lncRNA-disease association inference based on lncRNA expression profiles. Bioinformatics 2013;29:2617-24
36. Yang G, Lu X, Yuan L. LncRNA: a link between RNA and cancer. Biochim Biophys Acta (BBA)-Gene Regul Mech 2014;1839:1097-109
37. Volders P-J, Verheggen K, Menschaert G, et al. An update on LNCipedia: a database for annotated human lncRNA sequences. Nucleic Acids Res 2015;43:4363-4
38. Volders P-J, Helsens K, Wang X, et al. LNCipedia: a database for annotated human lncRNA transcript sequences and structures. Nucleic Acids Res 2013;41:D246-51
39. Amaral PP, Clark MB, Gascoigne DK, et al. lncRNAdb: a reference database for long noncoding RNAs. Nucleic Acids Res 2011;39:D146-51
40. Qiu M-T, Hu J-W, Yin R, et al. Long noncoding RNA: an emerging paradigm of cancer research. Tumor Biol 2013;34:613-20
41. Brannan CI, Dees EC, Ingram RS, et al. The product of the H19 gene may function as an RNA. Mol Cell Biol 1990;10:28-36
42. Brockdorff N, Ashworth A, Kay GF, et al. The product of the mouse Xist gene is a 15 kb inactive X-specific transcript containing no conserved ORF and located in the nucleus. Cell 1992;71:515-26
43. Brown CJ, Hendrich BD, Rupert JL, et al. The human XIST gene: analysis of a 17 kb inactive X-specific RNA that contains conserved repeats and is highly localized within the nucleus. Cell 1992;71:527-42
44. Feil R, Walter J, Allen ND, et al. Developmental control of allelic methylation in the imprinted mouse Igf2 and H19 genes. Development. 1994;120:2933-43
45. Guttman M, Amit I, Garber M, et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 2009;458:223-7
46. Cabili MN, Trapnell C, Goff L, et al. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev 2011;25: 1915-27
47. Quek XC, Thomson DW, Maag JL, et al. lncRNAdb v2. 0: expanding the reference database for functional long noncoding RNAs. Nucleic Acids Res 2015;43:D168-73
48. Liu C, Bai B, Skogerbø G, et al. NONCODE: an integrated knowledge database of non-coding RNAs. Nucleic Acids Res 2005;33:D112-5
49. He S, Liu C, Skogerbø G, et al. NONCODE v2. 0: decoding the non-coding. Nucleic Acids Res 2008;36:D170-2
50. Bu D, Yu K, Sun S, et al. NONCODE v3. 0: integrative annotation of long noncoding RNAs. Nucleic Acids Res 2012;40:D210-5
51. Xie C, Yuan J, Li H, et al. NONCODEv4: exploring the world of long non-coding RNA genes. Nucleic Acids Res 2014;42: D98-103
52. Zhao Y, Li H, Fang S, et al. NONCODE 2016: an informative and valuable data source of long non-coding RNAs. Nucleic Acids Res 2016;44:D203-8
53. Jin J, Liu J, Wang H, et al. PLncDB: plant long non-coding RNA database. Bioinformatics 2013;29:1068-71
54. Guttman M, Garber M, Levin JZ, et al. Ab initio reconstruction of cell type-specific transcriptomes in mouse reveals the conserved multi-exonic structure of lincRNAs. Nat Biotechnol 2010;28:503-10
55. Tahira AC, Kubrusly MS, Faria MF, et al. Long noncoding intronic RNAs are differentially expressed in primary and metastatic pancreatic cancer. Mol Cancer 2011;10:1476-59
56. Louro R, Smirnova AS, Verjovski-Almeida S. Long intronic noncoding RNA transcription: expression noise or expression choice? Genomics 2009;93:291-8
57. Poliseno L, Salmena L, Zhang J, et al. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 2010;465:1033-8
58. Salmena L, Poliseno L, Tay Y, et al. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell 2011;146: 353-8
59. Yin Y, Zhao Y, Wang J, et al. antiCODE: a natural senseantisense transcripts database. BMC Bioinformatics 2007; 8:319
60. Katayama S, Tomaru Y, Kasukawa T, et al. Antisense transcription in the mammalian transcriptome. Science 2005;309:1564-6
61. Lehner B, Williams G, Campbell RD, et al. Antisense transcripts in the human genome. Trends Genet 2002;18:63-5
62. Kapranov P, Cheng J, Dike S, et al. RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science 2007;316:1484-8
63. Preker P, Nielsen J, Kammler S, et al. RNA exosome depletion reveals transcription upstream of active human promoters. Science 2008;322:1851-4
64. Liu W-M, Chu W-M, Choudary PV, et al. Cell stress and translational inhibitors transiently increase the abundance of mammalian SINE transcripts. Nucleic Acids Res 1995;23: 1758-65
65. Espinoza CA, Goodrich JA, Kugel JF. Characterization of the structure, function, and mechanism of B2 RNA, an ncRNA repressor of RNA polymerase II transcription. RNA 2007;13:583-96
66. Mariner PD, Walters RD, Espinoza CA, et al. Human Alu RNA is a modular transacting repressor of mRNA transcription during heat shock. Mol Cell 2008;29:499-509
67. Kim T-K, Hemberg M, Gray JM, et al. Widespread transcription at neuronal activity-regulated enhancers. Nature 2010; 465:182-7
68. Rinn JL, Chang HY. Genome regulation by long noncoding RNAs. Annu Rev Biochem 2012;81:145-66
69. Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell 2009;136:629-41
70. Nam J-W, Bartel DP. Long noncoding RNAs in C. elegans. Genome Res 2012;22:2529-40
71. Tsai M-C, Spitale RC, Chang HY. Long intergenic noncoding RNAs: new links in cancer progression. Cancer Res 2011; 71:3-7
72. Ma H, Hao Y, Dong X, et al. Molecular mechanisms and function prediction of long noncoding RNA. Sci World J 2012; 2012:541786
73. Mercer TR, Dinger ME, Sunkin SM, et al. Specific expression of long noncoding RNAs in the mouse brain. Proc Natl Acad Sci USA 2008;105:716-21
74. Pauli A, Valen E, Lin MF, et al. Systematic identification of long noncoding RNAs expressed during zebrafish embryogenesis. Genome Res 2012;22:577-91
75. Hrdlickova B, de Almeida RC, Borek Z, et al. Genetic variation in the non-coding genome: involvement of micro-RNAs and long non-coding RNAs in disease. Biochim Biophys Acta 2014;1842:1910-22
76. Zhao T, Xu J, Liu L, et al. Identification of cancer-related lncRNAs through integrating genome, regulome and transcriptome features. Mol Biosyst 2015;11:126-36
77. Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature 2001;409:860-921
78. Qureshi IA, Mattick JS, Mehler MF. Long non-coding RNAs in nervous system function and disease. Brain Res 2010;1338:20-35
79. Liao Q, Liu C, Yuan X, et al. Large-scale prediction of long non-coding RNA functions in a coding-non-coding gene coexpression network. Nucleic Acids Res 2011;39:3864-78
80. Moran VA, Perera RJ, Khalil AM. Emerging functional and mechanistic paradigms of mammalian long non-coding RNAs. Nucleic Acids Res 2012;40:6391-400
81. Zhu J, Fu H, Wu Y, et al. Function of lncRNAs and approaches to lncRNA-protein interactions. Sci China Life Sci 2013;56:876-85
82. Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet 2009;10:155-9
83. Li X, Wu Z, Fu X, et al. lncRNAs: insights into their function and mechanics in underlying disorders. Mutat Res/Rev Mutat Res 2014;762:1-21
84. Grote P, Wittler L, Hendrix D, et al. The tissue-specific lncRNA Fendrr is an essential regulator of heart and body wall development in the mouse. Dev Cell 2013;24:206-14
85. Geisler S, Coller J. RNA in unexpected places: long noncoding RNA functions in diverse cellular contexts. Nat Rev Mol Cell Biol 2013;14:699-712
86. Saxena A, Carninci P. Long non-coding RNA modifies chromatin. Bioessays 2011;33:830-9
87. Lee JT. Lessons from X-chromosome inactivation: long ncRNA as guides and tethers to the epigenome. Genes Dev 2009;23:1831-42
88. Pandey RR, Mondal T, Mohammad F, et al. Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation. Mol Cell 2008;32:232-46
89. Rinn JL, Kertesz M, Wang JK, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 2007;129:1311-23
90. Khalil AM, Guttman M, Huarte M, et al. Many human large intergenic noncoding RNAs associate with chromatinmodifying complexes and affect gene expression. Proc Natl Acad Sci USA 2009;106:11667-72
91. Nagano T, Mitchell JA, Sanz LA, et al. The air noncoding RNA epigenetically silences transcription by targeting G9a to chromatin. Science 2008;322:1717-20
92. Terranova R, Yokobayashi S, Stadler MB, et al. Polycomb group proteins Ezh2 and Rnf2 direct genomic contraction and imprinted repression in early mouse embryos. Dev Cell 2008;15:668-79
93. Tsai M-C, Manor O, Wan Y, et al. Long noncoding RNA as modular scaffold of histone modification complexes. Science 2010;329:689-93
94. Umlauf D, Goto Y, Cao R, et al. Imprinting along the Kcnq1 domain on mouse chromosome 7 involves repressive histone methylation and recruitment of Polycomb group complexes. Nat Genet 2004;36:1296-300
95. Zhao J, Sun BK, Erwin JA, et al. Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome. Science 2008;322:750-6
96. Kaneko S, Li G, Son J, et al. Phosphorylation of the PRC2 component Ezh2 is cell cycle-regulated and up-regulates its binding to ncRNA. Genes Dev 2010;24:2615-20
97. Spizzo R, Almeida MI, Colombatti A, et al. Long non-coding RNAs and cancer: a new frontier of translational research& quest. Oncogene 2012;31:4577-87
98. Cheetham S, Gruhl F, Mattick J, et al. Long noncoding RNAs and the genetics of cancer. Br J Cancer 2013;108:2419-25
99. Gutschner T, Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol 2012;9:703-19
100. Guffanti A, Iacono M, Pelucchi P, et al. A transcriptional sketch of a primary human breast cancer by 454 deep sequencing. BMC Genomics 2009;10:163
101. Wang J, Liu X, Wu H, et al. CREB up-regulates long noncoding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res 2010;38: 5366-83
102. Jendrzejewski J, He H, Radomska HS, et al. The polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor suppressor type. Proc Natl Acad Sci 2012;109:8646-51
103. Ji P, Diederichs S, Wang W, et al. MALAT-1, a novel noncoding RNA, and thymosin b4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 2003;22: 8031-41
104. Guan Y, Kuo W-L, Stilwell JL, et al. Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer. Clin Cancer Res 2007;13:5745-55
105. Pasmant E, Sabbagh A, Vidaud M, et al. ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. FASEB J 2011;25:444-8
106. Chen G, Wang Z, Wang D, et al. LncRNADisease: a database for long-non-coding RNA-associated diseases. Nucleic Acids Res 2013;41:D983-6
107. Yang F, Zhang L, Huo XS, et al. Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Hepatology 2011;54:1679-89
108. Chen W, Böcker W, Brosius J, et al. Expression of neural BC200 RNA in human tumours. J Pathol 1997;183:345-51
109. Donahue HJ, Genetos DC. Genomic approaches in breast cancer research. Brief Funct Genomics 2013;12:391-6
110. Karagoz K, Sinha R, Arga KY. Triple negative breast cancer: a multi-omics network discovery strategy for candidate targets and driving pathways. Omics: A J Integr Biol 2015;19:115-30
111. Meng J, Li P, Zhang Q, et al. A four-long non-coding RNA signature in predicting breast cancer survival. J Exp Clin Cancer Res 2014;33:84
112. Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs. Mol Cell 2011;43:904-14
113. Barsyte-Lovejoy D, Lau SK, Boutros PC, et al. The c-Myc oncogene directly induces the H19 noncoding RNA by allelespecific binding to potentiate tumorigenesis. Cancer Res 2006;66:5330-7
114. Lottin S, Adriaenssens E, Dupressoir T, et al. Overexpression of an ectopic H19 gene enhances the tumorigenic properties of breast cancer cells. Carcinogenesis 2002;23:1885-95
115. Tessier CR, Doyle GA, Clark BA, et al. Mammary tumor induction in transgenic mice expressing an RNA-binding protein. Cancer Res 2004;64:209-14
116. Iacoangeli A, Lin Y, Morley EJ, et al. BC200 RNA in invasive and preinvasive breast cancer. Carcinogenesis 2004;25:2125-33
117. Pasmant E, Laurendeau I, Héron D, et al. Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF. Cancer Res 2007;67:3963-9
118. Mourtada-Maarabouni M, Pickard M, Hedge V, et al. GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene 2009;28:195-208
119. Huarte M, Guttman M, Feldser D, et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 2010;142:409-19
120. Vincent-Salomon A, Ganem-Elbaz C, Manié E, et al. X inactive-specific transcript RNA coating and genetic instability of the X chromosome in BRCA1 breast tumors. Cancer Res 2007;67:5134-40
121. Rodriguez BA, Weng Y-I, Liu T-M, et al. Estrogen-mediated epigenetic repression of the imprinted gene cyclin dependent kinase inhibitor 1C in breast cancer cells. Carcinogenesis 2011;32:812-21
122. Bavarva JH, Tae H, Settlage RE, et al. Characterizing the genetic basis for nicotine induced cancer development: a transcriptome sequencing study. PLoS One 2013;8:e67252
123. Wood SL, Pernemalm M, Crosbie PA, et al. Molecular histology of lung cancer: from targets to treatments. Cancer Treat Rev 2015;41:361-75
124. White NM, Cabanski CR, Silva-Fisher JM, et al. Transcriptome sequencing reveals altered long intergenic non-coding RNAs in lung cancer. Genome Biol 2014;15:429
125. Liu J, Lee W, Jiang Z, et al. Genome and transcriptome sequencing of lung cancers reveal diverse mutational and splicing events. Genome Res 2012;22:2315-27
126. Liu B, Fang L, Chen J, et al. miRNA-dis: microRNA precursor identification based on distance structure status pairs. Mol Biosyst 2015;11:1194-204
127. Shi X, Sun M, Liu H, et al. A critical role for the long noncoding RNA GAS5 in proliferation and apoptosis in nonsmall-cell lung cancer. Mol Carcinog 2013;54:E1-12
128. He Y, Meng X-M, Huang C, et al. Long noncoding RNAs: novel insights into hepatocelluar carcinoma. Cancer Lett 2014;344: 20-7
129. Venook AP, Papandreou C, Furuse J, et al. The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist 2010;15:5-13
130. Edenvik P, Davidsdottir L, Oksanen A, et al. Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice? Liver Int 2015;35:1862-71
131. Song P, Feng X, Zhang K, et al. Screening for and surveillance of high-risk patients with HBV-related chronic liver disease: promoting the early detection of hepatocellular carcinoma in China. Biosci Trends 2013;7:1-6
132. Wei Q, Guo P, Mu K, et al. Estrogen suppresses hepatocellular carcinoma cells through ERb-mediated upregulation of the NLRP3 inflammasome. Lab Invest 2015;95:804-16
133. Fu SC, Huang YW, Wang TC, et al. Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with new onset diabetes: a nationwide cohort study. Aliment Pharmacol Ther 2015;41:1200-9
134. Zhang L, Yang F, Yuan J-H, et al. Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma. Carcinogenesis 2012;34:577-86
135. Huang J-L, Zheng L, Hu Y-W. Characteristics of long noncoding RNA and its relation to hepatocellular carcinoma. Carcinogenesis 2013;35:507-14
136. Panzitt K, Tschernatsch MM, Guelly C, et al. Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology 2007;132:330-42
137. Yuan J-H, Yang F, Wang F, et al. A long noncoding RNA activated by TGF-b promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer Cell 2014;25:666-81
138. Yang F, Huo X-s, Yuan S-x, et al. Repression of the long noncoding RNA-LET by histone deacetylase 3 contributes to hypoxia-mediated metastasis. Mol Cell 2013;49:1083-96
139. Schonrock N, Götz J. Decoding the non-coding RNAs in Alzheimer's disease. Cell Mol Life Sci 2012;69:3543-59
140. Palop JJ, Chin J, Mucke L. A network dysfunction perspective on neurodegenerative diseases. Nature 2006;443:768-73
141. Tan L, Yu J-T, Hu N, et al. Non-coding RNAs in Alzheimer's disease. Mol Neurobiol 2013;47:382-93
142. Ng S-Y, Lin L, Soh BS, et al. Long noncoding RNAs in development and disease of the central nervous system. Trends Genet 2013;29:461-8
143. Mus E, Hof PR, Tiedge H. Dendritic BC200 RNA in aging and in Alzheimer's disease. Proc Natl Acad Sci USA 2007;104: 10679-84
144. Li D, Chen G, Yang J, et al. Transcriptome analysis reveals distinct patterns of long noncoding RNAs in heart and plasma of mice with heart failure. PLoS One 2013;8:e77938
145. Kaya Z, Leib C, Katus HA. Autoantibodies in heart failure and cardiac dysfunction. Circ Res 2012;110:145-58
146. Barsheshet A, Brenyo A, Goldenberg I, et al. Sex-related differences in patients' responses to heart failure therapy. Nat Rev Cardiol 2012;9:234-42
147. Papait R, Kunderfranco P, Stirparo GG, et al. Long noncoding RNA: a new player of heart failure? J Cardiovasc Transl Res 2013;6:876-83
148. Kumarswamy R, Bauters C, Volkmann I, et al. Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failure. Circ Res 2014;114:1569-75
149. Benetatos L, Vartholomatos G, Hatzimichael E. MEG3 imprinted gene contribution in tumorigenesis. Int J Cancer 2011;129:773-9
150. Zhao J, Dahle D, Zhou Y, et al. Hypermethylation of the promoter region is associated with the loss of MEG3 gene expression in human pituitary tumors. J Clin Endocrinol Metab 2005;90:2179-86
151. Gejman R, Batista DL, Zhong Y, et al. Selective loss of MEG3 expression and intergenic differentially methylated region hypermethylation in the MEG3/DLK1 locus in human clinically nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 2008;93:4119-25
152. Cheunsuchon P, Zhou Y, Zhang X, et al. Silencing of the imprinted DLK1-MEG3 locus in human clinically nonfunctioning pituitary adenomas. Am J Pathol 2011;179:2120-30
153. Wallace C, Smyth DJ, Maisuria-Armer M, et al. The imprinted DLK1-MEG3 gene region on chromosome 14q32. 2 alters susceptibility to type 1 diabetes. Nat Genet 2010;42:68-71
154. Martens-Uzunova ES, Böttcher R, Croce CM, et al. Long noncoding RNA in prostate, bladder, and kidney cancer. Eur Urol 2014;65:1140-51
155. Jiang YJ, Bikle DD. LncRNA: a new player in 1a, 25 (OH) 2 vitamin D3/VDR protection against skin cancer formation. Exp Dermatol 2014;23:147-50
156. Luo M, Li Z, Wang W, et al. Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression. Cancer Lett 2013;333:213-21
157. Kim NH, Lee CH, Lee AY. H19 RNA downregulation stimulated melanogenesis in melasma. Pigment Cell Melanoma Res 2010;23:84-92
158. Shi X, Sun M, Liu H, et al. Long non-coding RNAs: a new frontier in the study of human diseases. Cancer Lett 2013;339: 159-66
159. Scott RH, Murray A, Baskcomb L, et al. Stratification of Wilms tumor by genetic and epigenetic analysis. Oncotarget 2012;3:327-35
160. De Baun MR, Niemitz EL, Mc Neil DE, et al. Epigenetic alterations of H19 and LIT1 distinguish patients with Beckwith-Wiedemann syndrome with cancer and birth defects. Am J Hum Genet 2002;70:604-11
161. Lottin S, Adriaenssens E, Berteaux N, et al. The human H19 gene is frequently overexpressed in myometrium and stroma during pathological endometrial proliferative events. Eur J Cancer 2005;41:168-77
162. Nakagawa T, Endo H, Yokoyama M, et al. Large noncoding RNA HOTAIR enhances aggressive biological behavior and is associated with short disease-free survival in human nonsmall cell lung cancer. Biochem Biophys Res Commun 2013;436:319-24
163. Geng Y, Xie S, Li Q, et al. Large intervening non-coding RNA HOTAIR is associated with hepatocellular carcinoma progression. J Int Med Res 2011;39:2119-28
164. Zhang A, Xu M, Mo Y-Y. Role of the lncRNA-p53 regulatory network in cancer. J Mol Cell Biol 2014;6:181-91
165. Zhuang Y, Wang X, Nguyen HT, et al. Induction of long intergenic non-coding RNA HOTAIR in lung cancer cells by type I collagen. J Hematol Oncol 2013;6:35
166. Niinuma T, Suzuki H, Nojima M, et al. Upregulation of miR-196a and HOTAIR drive malignant character in gastrointestinal stromal tumors. Cancer Res 2012;72:1126-36
167. Svoboda M, Slyskova J, Schneiderova M, et al. HOTAIR long non-coding RNA is a negative prognostic factor not only in primary tumors, but also in the blood of colorectal cancer patients. Carcinogenesis 2014;35:1510-5
168. Liu X, Sun M, Nie F, et al. Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer. Mol Cancer 2014; 13:92
169. Gutschner T, Hämmerle M, Eißmann M, et al. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res 2013;73:1180-9
170. Qi P, Du X. The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine. Mod Pathol 2013;26:155-65
171. Ying L, Chen Q, Wang Y, et al. Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelialto-mesenchymal transition. Mol Biosyst 2012;8:2289-94
172. Guay C, Jacovetti C, Nesca V, et al. Emerging roles of noncoding RNAs in pancreatic b-cell function and dysfunction. Diabetes Obes Metab 2012;14:12-21
173. Graham M, Adams JM, Cory S, Murine T. lymphomas with retroviral inserts in the chromosomal 15 locus for plasmacytoma variant translocations. EMBO J 1985;4:675-81
174. Beck-Engeser GB, Lum AM, Huppi K, et al. Pvt1-encoded microRNAs in oncogenesis. Retrovirology 2008;5:4
175. Ma L, Li A, Zou D, et al. LncRNAWiki: harnessing community knowledge in collaborative curation of human long noncoding RNAs. Nucleic Acids Res 2014;43:D187-92
176. Ning S, Zhang J, Wang P, et al. Lnc2Cancer: a manually curated database of experimentally supported lncRNAs associated with various human cancers. Nucleic Acids Res 2016;44: D980-5
177. Jiang Q, Wang J, Wu X, et al. LncRNA2Target: a database for differentially expressed genes after lncRNA knockdown or overexpression. Nucleic Acids Res 2015;43:D193-6
178. Paraskevopoulou MD, Georgakilas G, Kostoulas N, et al. DIANA-LncBase: experimentally verified and computationally predicted microRNA targets on long non-coding RNAs. Nucleic Acids Res 2013;41:D239-45
179. Chakraborty S, Deb A, Maji RK, et al. LncRBase: an enriched resource for lncRNA information. PloS One 2014;9:e108010
180. Bhartiya D, Pal K, Ghosh S, et al. lncRNome: a comprehensive knowledgebase of human long noncoding RNAs. Database 2013;2013:bat034
181. Gallart AP, Pulido AH, de Lagrán IAM, et al. GREENC: a Wikibased database of plant lncRNAs. Nucleic Acids Res 2016;44:D1161-6
182. Ning S, Zhao Z, Ye J, et al. SNP@ lincTFBS: an integrated database of polymorphisms in human LincRNA transcription factor binding sites. PloS One 2014;9:e103851
183. Gong J, Liu W, Zhang J, et al. lncRNASNP: a database of SNPs in lncRNAs and their potential functions in human and mouse. Nucleic Acids Res 2015;43:D181-6
184. Li J, Gao C, Wang Y, et al. A bioinformatics method for predicting long noncoding RNAs associated with vascular disease. Sci China Life Sci 2014;57:852-7
185. Wang Y, Chen L, Chen B, et al. Mammalian ncRNA-disease repository: a global view of ncRNA-mediated disease network. Cell Death Dis 2013;4:e765
186. Li J, Ma W, Zeng P, et al. LncTar: a tool for predicting the RNA targets of long noncoding RNAs. Brief Bioinformatics 2015;16:806-12
187. Ferrè F, Colantoni A, Helmer-Citterich M. Revealing protein-lncRNA interaction. Brief Bioinformatics 2016;17:106-16
188. Yotsukura S, Hancock T, Natsume-Kitatani Y, et al. Computational recognition for long non-coding RNA (lncRNA): software and databases. Brief Bioinformatics 2016;bbv114
189. Chen X, Liu MX, Cui QH, et al. Prediction of disease-related interactions between MicroRNAs and environmental factors based on a semi-supervised classifier. PLoS One 2012;7:e43425
190. Chen X, Liu MX, Yan G. RWRMDA: predicting novel human microRNA-disease associations. Mol Biosyst 2012;8:2792-8
191. Chen X, Yan CC, Zhang X, et al. RBMMMDA: predicting multiple types of disease-microRNA associations. Sci Rep 2015;5:13877
192. Chen X, Yan G-Y. Semi-supervised learning for potential human microRNA-disease associations inference. Sci Rep 2014;4:5501
193. Chen X, Yan GY, Liao XP. A novel candidate disease genes prioritization method based on module partition and rank fusion. OMICS: J Integr Biol 2010;14:337-56
194. Chen X. miREFRWR: a novel disease-related microRNA-environmental factor interactions prediction method. Mol Biosyst 2016;12:624-33
195. Chen X, Yan CC, Zhang X, et al. WBSMDA: within and between score for MiRNA-disease association prediction. Sci Rep 2016;6:21106
196. Huang Y, Chen X, You Z, et al. ILNCSIM: improved lncRNA functional similarity calculation model. Oncotarget 2016;7:25902-14
197. Sun J, Shi H, Wang Z, et al. Inferring novel lncRNA-disease associations based on a random walk model of a lncRNA functional similarity network. Mol Biosyst 2014;10:2074-81
198. Liu Y, Zhang R, Qiu F, et al. Construction of a lncRNA-PCG bipartite network and identification of cancer-related lncRNAs: a case study in prostate cancer. Mol Biosyst 2015;11:384-93
199. Zhou M, Wang X, Li J, et al. Prioritizing candidate diseaserelated long non-coding RNAs by walking on the heterogeneous lncRNA and disease network. Mol Biosyst 2015;11: 760-9
200. Ganegoda GU, Li M, Wang W, et al. Heterogeneous network model to infer human disease-long intergenic non-coding RNA associations. IEEE Trans Nanobiosci 2015;14:175-83
201. Chen X. KATZLDA: KATZ measure for the lncRNA-disease association prediction. Sci Rep 2015;5:16840
202. Yang X, Gao L, Guo X, et al. A network based method for analysis of lncRNA-disease associations and prediction of lncRNAs implicated in diseases. PLoS One 2014;9:e87797
203. Liu M-X, Chen X, Chen G, et al. A computational framework to infer human disease-associated long noncoding RNAs. PLoS One 2014;9:e84408
204. Chen X. Predicting lncRNA-disease associations and constructing lncRNA functional similarity network based on the information of miRNA. Sci Rep 2015;5:13186
205. Takahashi Y, Sawada G, Kurashige J, et al. Amplification of PVT-1 is involved in poor prognosis via apoptosis inhibition in colorectal cancers. Br J Cancer 2014;110:164-71
206. Tanaka K, Shiota G, Meguro M, et al. Loss of imprinting of long QT intronic transcript 1 in colorectal cancer. Oncology 2000;60:268-73
207. Wang H-M, Lu J-H, Chen W-Y, et al. Upregulated lncRNAUCA1 contributes to progression of lung cancer and is closely related to clinical diagnosis as a predictive biomarker in plasma. Int J Clin Exp Med 2015;8:11824-30
208. Tano K, Mizuno R, Okada T, et al. MALAT-1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility-related genes. FEBS Lett 2010;584: 4575-80
209. Zhang E, Yin D, Sun M, et al. P53-regulated long non-coding RNA TUG1 affects cell proliferation in human non-small cell lung cancer, partly through epigenetically regulating HOXB7 expression. Cell Death Dis 2014;5:e1243
210. Choudhry H, Albukhari M, Morotti A, et al. Tumor hypoxia induces nuclear paraspeckle formation through HIF-2a dependent transcriptional activation of NEAT1 leading to cancer cell survival, Oncogene 2014;34:4546
211. Guo X, Xia J, Deng K. Long non-coding RNAs: emerging players in gastric cancer, tumor. Biology 2014;35:10591-600
212. Wang J, Su L, Chen X, et al. MALAT1 promotes cell proliferation in gastric cancer by recruiting SF2/ASF. Biomed Pharmacother 2014;68:557-64
213. Jalali S, Kapoor S, Sivadas A, et al. Computational approaches towards understanding human long noncoding RNA biology. Bioinformatics 2015;31:2241-51
214. Wapinski O, Chang HY. Long noncoding RNAs and human disease. Trends Cell Biol 2011;21:354-61
215. Park Y, Marcotte EM. Flaws in evaluation schemes for pairinput computational predictions. Nat Methods 2012;9:1134-6